This guidance provides recommendations to sponsors for collection of a core set of patient-reported clinical outcomes in cancer clinical trials and related considerations for instrument selection and trial design.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3wbTAls
No comments:
Post a Comment